Molting in crustaceans is a highly complex physiological process involving regulation by two paired endocrine glands, the X-organ/sinus gland complex (XO/SG) and the Y-organ (YO). The XO/SG complex is responsible for making molt-inhibiting hormone, which negatively regulates synthesis of molting hormones, ecdysteroids, by the YO. In this study, changes in protein abundance in the YO were characterized over the course of a molt cycle induced by multiple leg autotomy in the blackback land crab, Gecarcinus lateralis. In all, 457 distinct protein spots were detected using two-dimensional gel electrophoresis, of which 230 (50%) changed significantly in abundance over the course of the molt cycle. Protein abundance differed most notably between intermolt and the three premolt stages, indicative of a biological 'on-off' switch. Changes in hemolymph proteins were correlated with stage-specific processes of sclerotization and melanization that facilitate cuticle hardening and support immune reactions. An abundance of cytoskeletal proteins were identified, which corresponded with glandular hypertrophy associated with synthesis and secretion of ecdysteroids. Many proteins involved in energetic pathways including glycolysis, the citric acid cycle, amino acid metabolism, and one‑carbon metabolism changed in abundance in response to increasing energy demands and the requirement for precursors of macromolecular synthesis. Several proteins involved in immune, proteostasis, and oxidative stress responses were correlated with the dynamic and demanding cellular changes associated with ecdysteroidogenesis. These changes in diverse physiological pathways represent the complexity involved with molecular regulation of the YO in decapod crustaceans.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cbd.2018.11.011 | DOI Listing |
Aquat Toxicol
January 2025
College of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, 712100, China. Electronic address:
World J Microbiol Biotechnol
March 2024
e-nema GmbH, Klausdorfer Str. 28-36, 24223, Schwentinental, Germany.
The entomopathogenic nematode Heterorhabditis bacteriophora, symbiotically associated with enterobacteria of the genus Photorhabdus, is a biological control agent against many insect pests. Dauer Juveniles (DJ) of this nematode are produced in industrial-scale bioreactors up to 100 m in liquid culture processes lasting approximately 11 days. A high DJ yield (> 200,000 DJ·mL) determines the success of the process.
View Article and Find Full Text PDFMicroPubl Biol
October 2023
Department of Molecular, Cell, and Developmental Biology, University of California, Santa Cruz, Santa Cruz, California, United States.
The auxin-inducible degron (AID) system is a widely-used system for conditional protein depletion. During the course of an experiment, we depleted the nuclear hormone receptor transcription factor NHR-23 to study molting, and we recovered a spontaneous suppressor allele that bypassed the L1 larval arrest caused by NHR-23 depletion. These mutants also failed to deplete a BFP::AID reporter in the strain background, suggesting a broader defect in the AID system.
View Article and Find Full Text PDFPharmaceutics
March 2023
Departments of Pharmaceutics, University of Washington, Seattle, WA 98195, USA.
Leukemia remains incurable partly due to difficulties in reaching and maintaining therapeutic drug concentrations in the target tissues and cells. Next-generation drugs targeted to multiple cell checkpoints, including the orally active venetoclax (Bcl-2 target) and zanubrutinib (BTK target), are effective and have improved safety and tolerability compared to conventional, nontargeted chemotherapies. However, dosing with a single agent frequently leads to drug resistance; asynchronous coverage due to the peak-and-trough time-course of two or more oral drugs has prevented drug combinations from simultaneously knocking out the respective drugs' targets for sustained leukemia suppression.
View Article and Find Full Text PDFMult Scler Relat Disord
January 2023
Neurology, Pontificia Universidad Católica de Chile, Santiago, Chile; Neurology, Hospital Sótero del Río, Santiago, Chile. Electronic address:
Background: Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Associated Disease (MOGAD) is an emerging disorder recognized as a clinical entity distinct from Multiple Sclerosis and Aquaporin-4-positive Neuromyelitis Optica Spectrum Disorders (NMOSD-AQP4+), and its phenotypic spectrum continues to expand. Most information about its clinical course has emerged from retrospective studies, and treatment response both in acute and chronic-relapsing disease is still limited. We aimed to describe the clinical and paraclinical characteristics of monophasic and relapsing, paediatric and adult patients with MOGAD under regular clinical care in Chile, highlighting some challenging cases that are far from being considered benign.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!